Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot Israel

Showing results (171-180 of 322) with videos related to

Pageof 33
Sort By:
The Journal of Allergy and Clinical Immunology|May 25, 2017
Income is an independent risk factor for worse asthma outcomesJuan Carlos Cardet, Margee Louisias, Tonya S King, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2012
Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseasesXingnan Li, Elizabeth J Ampleford, Timothy D Howard, et al.
The New England Journal of Medicine|October 27, 2021
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe AsthmaMichael E Wechsler, Marcella K Ruddy, Ian D Pavord, et al.
Nature Communications|January 4, 2023
Antagonizing cholecystokinin A receptor in the lung attenuates obesity-induced airway hyperresponsivenessRonald Allan M Panganiban, Zhiping Yang, Maoyun Sun, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2020
Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation FrequencyMichael C Peters, David Mauger, Kristie R Ross, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 10, 2007
Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilationRonald L Sorkness, Eugene R Bleecker, William W Busse, et al.
The Journal of Allergy and Clinical Immunology|January 14, 2018
A functional splice variant associated with decreased asthma risk abolishes the ability of gasdermin B to induce epithelial cell pyroptosisRonald A Panganiban, Maoyun Sun, Amber Dahlin, et al.
Nature Communications|April 25, 2018
The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammationMorris Nechama, Jeahoo Kwon, Shuo Wei, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 14, 2023
Association of Sputum Eosinophilia With Easily Measured Type-2 Inflammatory Biomarkers in Untreated Mild Persistent AsthmaRonina Covar, Stephen C Lazarus, Jerry A Krishnan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 18, 2024
Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 AsthmaIan D Pavord, Klaus F Rabe, Elliot Israel, et al.
Pageof 33

Showing results (171-180 of 322) with videos related to

Sort By:
Pageof 33
The Journal of Allergy and Clinical Immunology|May 25, 2017
Income is an independent risk factor for worse asthma outcomesJuan Carlos Cardet, Margee Louisias, Tonya S King, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2012
Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseasesXingnan Li, Elizabeth J Ampleford, Timothy D Howard, et al.
The New England Journal of Medicine|October 27, 2021
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe AsthmaMichael E Wechsler, Marcella K Ruddy, Ian D Pavord, et al.
Nature Communications|January 4, 2023
Antagonizing cholecystokinin A receptor in the lung attenuates obesity-induced airway hyperresponsivenessRonald Allan M Panganiban, Zhiping Yang, Maoyun Sun, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2020
Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation FrequencyMichael C Peters, David Mauger, Kristie R Ross, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 10, 2007
Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilationRonald L Sorkness, Eugene R Bleecker, William W Busse, et al.
The Journal of Allergy and Clinical Immunology|January 14, 2018
A functional splice variant associated with decreased asthma risk abolishes the ability of gasdermin B to induce epithelial cell pyroptosisRonald A Panganiban, Maoyun Sun, Amber Dahlin, et al.
Nature Communications|April 25, 2018
The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammationMorris Nechama, Jeahoo Kwon, Shuo Wei, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 14, 2023
Association of Sputum Eosinophilia With Easily Measured Type-2 Inflammatory Biomarkers in Untreated Mild Persistent AsthmaRonina Covar, Stephen C Lazarus, Jerry A Krishnan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 18, 2024
Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 AsthmaIan D Pavord, Klaus F Rabe, Elliot Israel, et al.
Pageof 33